ALGN:NASDAQAlign Technology, Inc. Analysis
Data as of 2026-03-14 - not real-time
$164.23
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Align Technology delivered a strong fourth‑quarter beat, with revenue up 5.3% YoY and adjusted EPS rising 34.8% to $3.29, prompting analysts to lift their forecasts and maintain a consensus "Buy" rating. The company’s gross margin of 69.8% and operating margin of 22.4% underscore the high‑margin nature of its clear‑aligner and iTero scanner businesses, while cash on hand exceeds $1 billion and free cash flow remains robust at $483 million. However, the current price of $164.23 sits well above the DCF‑derived fair value of $128.70, implying a ~22% downside, and the trailing PE of 29x exceeds the industry average of 26x, signaling an overvalued valuation.
Technical indicators show the stock trading near its 20‑day SMA of $181.6 but below the 50‑day SMA of $175.0, with a bearish MACD histogram and an RSI of 36, suggesting short‑term oversold conditions but lingering bearish momentum. The beta of ~1.2 and 30‑day volatility of ~52% point to heightened price swings, while increasing volume and a bullish trend direction indicate continued market interest. Given the strong fundamentals but elevated valuation and risk profile, the outlook balances growth potential against price pressure.
Technical indicators show the stock trading near its 20‑day SMA of $181.6 but below the 50‑day SMA of $175.0, with a bearish MACD histogram and an RSI of 36, suggesting short‑term oversold conditions but lingering bearish momentum. The beta of ~1.2 and 30‑day volatility of ~52% point to heightened price swings, while increasing volume and a bullish trend direction indicate continued market interest. Given the strong fundamentals but elevated valuation and risk profile, the outlook balances growth potential against price pressure.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Recent earnings beat but price above fair value
- Bearish MACD and RSI near oversold levels
- Support around $162.33 and rising volume
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Revenue growth and expanding margins
- Forward PE of 13.4 indicating earnings upside
- Analyst consensus upgrade and positive earnings outlook
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Sustainable competitive moat in clear aligners and digital imaging
- Regulatory and reimbursement environment stability
- Valuation premium relative to peers
Key Metrics & Analysis
Financial Health
Revenue Growth5.30%
Profit Margin10.17%
P/E Ratio29.1
ROE10.39%
ROA6.94%
Debt/Equity2.83
P/B Ratio2.9
Op. Cash Flow$593.2M
Free Cash Flow$483.7M
Industry P/E26.2
Technical Analysis
TrendBullish
RSI36.7
Support$162.33
Resistance$192.69
MA 20$181.61
MA 50$175.04
MA 200$159.95
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Fair Value$128.70
Target Price$201.57
Upside/Downside22.74%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta1.23
Volatility51.96%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.